Hospital Pharmacies to Possess 40% Market Share for Cerebral Aneurysm Management Market: Future Market Insights, Inc. Study
Future Market Insights Global and Consulting Pvt. Ltd.
6 min read
Future Market Insights Global and Consulting Pvt. Ltd.
North America is expected to possess 45% market share for Cerebral aneurysm management market in 2023. Europe Cerebral aneurysm management market size is expected to possess 37% market share in 2023
NEWARK, Del, Feb. 15, 2023 (GLOBE NEWSWIRE) -- During the forecast period 2023 to 2033, the Cerebral Aneurysm Management Market is expected to grow at a value of 6.7% CAGR, according to Future Market Insights. By the year 2033, the global market for Cerebral aneurysm management is expected to rise up to a market valuation of US$ 1.56 Billion. The increase in demand for cerebral aneurysm management can be attributed to the aging population and the availability of various treatment options.
The growth of the cerebral aneurysm treatment market is driven by the increasing number of individuals with cerebrovascular disorders globally. Factors such as a rise in patients with high blood pressure, trauma to blood vessels, and unhealthy lifestyle habits like smoking contribute to the growth of the market. The increasing use of medical therapies for treating un-ruptured intracranial aneurysms, advancements in neurodegenerative disease drug discovery, and an increase in cigarette smokers responsible for brain cancer also play a role.
The improving healthcare infrastructure, increase in healthcare expenditure, and ongoing research and development efforts further boost the market. The market outlook for 2023 to 2033 is favorable, with opportunities for growth due to innovations in drugs and treatment options. Furthermore, North America and Europe are expected to be major contributors for the development of Cerebral aneurysm management market owing to the prevalence of geriatric population and technologically advanced healthcare infastructures.
Key Takeaways from the Market Study
The Cerebral aneurysm management market is expected to grow at a value of 6.7% CAGR in the forecast period 2023-2033.
By distribution channel, hospital pharmacies are expected to hold 40% of the market share in 2023 for Cerebral aneurysm management market.
North America is expected to possess 45% market share for Cerebral aneurysm management market in 2023.
Asia Pacific Cerebral aneurysm management market size is expected to possess 37% market share in 2023.
“Increase in technologically advanced healthcare infrastructures along with awareness of treating Cerebral aneurysm is driving the growth of the Cerebral aneurysm management market.” states an FMI analyst
Sanofi, a key player in the cerebral aneurysm management market is focusing on integrating technology to offer diagnostic test for treating cerebral aneurysm.
Biogen, another key player in the cerebral aneurysm management market is focusing on investing in research and development for innovating medications.
More Valuable Insights
Future Market Insights, in its new offering, presents an unbiased analysis of the global Cerebral aneurysm management market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.
The study reveals essential insights on the basis of Drug Class (Antihypertensives, Antiepileptics, Analgesics, Antiemetics, Antacids), Route of Administration (Oral, Injectable, Transdermal), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Region (North America, Latin America, Europe, South Asia, East Asia, Oceania, MEA)
The healthcare domain team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations with an objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 Billion+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis of key trends including competitive landscape, profit margin, and research development efforts
Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain
Hand Eczema (HE) Treatment Market Size: The global Hand Eczema (HE) Treatment Market is expected to garner a market value of US$ 53 Million in 2023 and is expected to accumulate a market value of US$ 114.42 Million by registering a CAGR of 8% in the forecast period 2023 to 2033.
Ear Health Market Share: The global ear health market holds a valuation of US$ 1.60 Billion by the end of the year 2022. Throughout the forecast period of 2023 to 2033, the market is likely to display growth at a CAGR of 6.4%, and is expected to hold a market value of around US$ 3.16 Billion in 2033.
Biodefense Market Growth: The global biodefense market size was valued at US$ 16.31 billion in the year 2023 and is estimated to reach a revised size of US$ 32.99 billion by 2033. This market is projected to expand at a CAGR of 7.3% during the analysis period.
Erythema Treatment Market Demand: The global erythema treatment market is expected to garner a market value of US$ 184.41 Million in 2023 and is expected to accumulate a market value of US$ 315 Million by registering a CAGR of 5.5% in the forecast period 2023 to 2033.
Epidemic Keratoconjunctivitis Treatment Market Opportunity: The global epidemic keratoconjunctivitis treatment market is expected to garner a market value of US$ 500 million in 2023 and is expected to accumulate a market value of US$ 814.45 million by registering a CAGR of 5% in the forecast period 2023 to 2033.
About Future Market Insights, Inc.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.
